From: BiaaarsUialui
To:
Cc: Paul Barrett
Subject: Re: Cost Basis
Date: Tuesday. October 10. 2017 2:17:07 PM
Cost basis of securities transferred in are as follows:
Thank you
Purchase Quantity
A§FehPRVIEIP@R&ip Inc. (Formerly Date Cost
1/16/01 70,500 1,500,000
Dress Barn 1.3.11)
Foundation Medicine Inc 1/16/14 49.830 1,265,037
Sangamo Therapeutics Inc 5/28/13 50,000 422,214
Richard Kahn
New York NY 10022
Phon
Cel
On Oct 10 2017 at 2:09 PM. <
wrote:
Hello, Richard. I wanted to follow up with you. My understanding is that there
may be some questions around cost basis for the assets that you transferred
over. How may I support you?
<image003.jpg>
SDNY_GM_00012327
CONFIDENTIAL
EFTA_00122976
EFTA01268400